Check this one out!
They just announced yesterday that they had a test that detected 100% of early-stage, min, and late-stage ovarian cancers in a study on 500 individuals. No missed cases. less than 23% false positives and 0% false negatives.
There is currently no screening technology for ovarian cancer. This makes it likely that large companies will be clamouring to bid on the tech. Which is a great thing. Early detection isn't common, but early detection can increase survival rates from 50% to 90%+ after 5 years. That is a very meaningful and tangible delta in terms of lives that will be saved once this is rolled-out world-wide.
I didn't have time to research them in-depth before buying in. But I will learn more about them if I have funds available to increase the position. Small-cap highly likely to attract buyers. Excellent work coming out of Australia! They have other tech in development, including a multi-cancer screening test. If the tech on that is as good as the tech announced yesterday, this could seriously improve the early-detection, treatment, and survival rates for a wide-swath of cancers.
Could you find a more positive story to invest in?
They just announced yesterday that they had a test that detected 100% of early-stage, min, and late-stage ovarian cancers in a study on 500 individuals. No missed cases. less than 23% false positives and 0% false negatives.
There is currently no screening technology for ovarian cancer. This makes it likely that large companies will be clamouring to bid on the tech. Which is a great thing. Early detection isn't common, but early detection can increase survival rates from 50% to 90%+ after 5 years. That is a very meaningful and tangible delta in terms of lives that will be saved once this is rolled-out world-wide.
I didn't have time to research them in-depth before buying in. But I will learn more about them if I have funds available to increase the position. Small-cap highly likely to attract buyers. Excellent work coming out of Australia! They have other tech in development, including a multi-cancer screening test. If the tech on that is as good as the tech announced yesterday, this could seriously improve the early-detection, treatment, and survival rates for a wide-swath of cancers.
Could you find a more positive story to invest in?
Trade active
Not really a trade. Likely to be a long-term buy and hold. Likely to add to position as we go. No way to really judge a price-target... but it is likely significantly higher.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.